Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Journal of Drugs in Dermatology : JDD|August 10, 2022
Single-Centre Real-Life Experience of Guselkumab in Patients with Moderate-to-Severe Plaque PsoriasisDario Marletta, Giulia Murgia, Angelo Cattaneo, et al.Photodermatology, Photoimmunology & Photomedicine|May 3, 2012
Tomesa balneophototherapy in mild to severe psoriasis: a retrospective clinical trial in 174 patientsAngelo Cattaneo, Silvia Alberti Violetti, Simona Tavecchio, et al.The Journal of Dermatological Treatment|February 23, 2026
Toward the definition of moderate psoriasis: an expert opinionAntonio Costanzo, Federico Bardazzi, Martina Burlando, et al.Women'S Health Reports (New Rochelle, N.Y.)|June 2, 2022
The CANOVA Study Real-World Evidence of Biologic Treatments in Moderate-Severe Psoriasis in Italy: A Gender PerspectiveDelia Colombo, Luca Bianchi, Gabriella Fabbrocini, et al.Dermatology and Therapy|February 19, 2026
Psychological Well-Being of Patients with Moderate-to-Severe Plaque Psoriasis Treated with Tildrakizumab: 28-Week Interim Results from a Multicenter Observational Study in Italy Using the DASS-21 Questionnaire, the BLUE StudyEmanuele Trovato, Claudio Bonifati, Simone Ribero, et al.BMC Health Services Research|September 7, 2021
A real-world economic analysis of biologic therapies for moderate-to-severe plaque psoriasis in Italy: results of the CANOVA observational longitudinal studyEmanuela Zagni, Luca Bianchi, Gabriella Fabbrocini, et al.Dermatologic Therapy|October 22, 2021
Real-world evidence of biologic treatments in moderate-severe psoriasis in Italy: Results of the CANOVA (EffeCtiveness of biologic treAtmeNts for plaque psOriasis in Italy: An obserVAtional longitudinal study of real-life clinical practice) studyDelia Colombo, Luca Bianchi, Gabriella Fabbrocini, et al.Pageof 1